Consequently, it potently stabilizes and activates wild-type, but not mutant p53 protein in tumour cells in contrast to chemotherapeutics whose mechanism of action, at least in part, relies on genotoxic activation of p53. The gene discussed is TP53; the disease is neoplasm.